Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Society for Developmental Biology medal recognises outstanding achievements in the field.

Associate Professor Tatjana Sauka-Spengler is this year's winner of the Cheryll Tickle medal, which is awarded annually to the mid-career female scientist for outstanding achievements in the developmental biology research. 

Professor Sauka-Spengler has been a research group leader in the MRC Weatherall Institute of Molecular Medicine (WIMM) since 2012, and she has also previously won the prestigious Lister Institute Research Prize (2013) and the March of Dimes Basil O’Connor Research Award (2013).

Dr. Filipa Simões  from Professor Sauka-Spengler's group said: “Simply put, Tatjana is an outstanding supervisor and mentor, not only to the people directly working with her, but also to any other junior scientist that approaches her for guidance”. 

Professor Sauka-Spengler said: "I am absolutely delighted but also very humbled by this honour. I am grateful to all my fantastic students, postdocs, my collaborator and mentors and my institutions MRC WIMM, RDM and University of Oxford - I think I am extremely lucky to work with such a brilliant group of people."

Many congratulations to Professor Sauka-Spengler!

Read more on the British Society of Developmental Biology website. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.